These effects, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the thought of targeting ACKR3 as a singular solution to modulate the opioid program, which could open new therapeutic avenues for opioid-related Diseases. Gene expression analysis revealed that ACKR3 https://daveyu738lbq3.buscawiki.com/user